NPPA fixed prices of 37 new drug formulations under DPCO 2013, covering diabetes, hypertension, respiratory and mental health ...

Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...

Updated versions of best-selling drugs may mitigate some of the impact of patent cliff losses, but the strategy behind the ...

Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

Making prescription painkillers harder to abuse is the goal of a specialty pharmaceutical company that’s just secured $22.5 million to complete late-stage trials and seek regulatory approval for its ...

AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

This collection is a collaboration between Frontiers in Drug Delivery and Frontiers’ flagship journal, Frontiers for Young Minds, an award‑winning, ...

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private ...